Differential Regulation of Cellular FAM111B by Human Adenovirus C Type 5 E1 Oncogenes.
E1B-55K
E4orf6
FAM111 trypsin-like peptidase B
adenovirus early region 1 (E1), E1A
antiviral host factor
human adenovirus
viral replication
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
28 05 2021
28 05 2021
Historique:
received:
07
05
2021
revised:
25
05
2021
accepted:
27
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
15
12
2021
Statut:
epublish
Résumé
The adenovirus type 5 (HAdV-C5) E1 transcription unit encodes regulatory proteins that are essential for viral replication and transformation. Among these, E1A and E1B-55K act as key multifunctional HAdV-C5 proteins involved in various steps of the viral replication cycle and in virus-induced cell transformation. In this context, HAdV-C5-mediated dysregulations of cellular factors such as the tumor suppressors p53 and pRB have been intensively investigated. However, cellular components of downstream events that could affect infection and viral transformation are widely unknown. We recently observed that cellular FAM111B is highly regulated in an E1A-dependent fashion. Intriguingly, previous reports suggest that FAM111B might play roles in tumorigenesis, but its exact functions are not known to date. Here, we set out to investigate the role of FAM111B in HAdV-C5 infections. We found that (i) FAM111B levels are upregulated early and downregulated late during infection, that (ii) FAM111B expression is differentially regulated, that (iii) FAM111B expression levels depend on the presence of E1B-55K and E4orf6 and that (iv) a FAM111B knockdown increases HAdV-C5 replication. Our data indicate that FAM111B acts as an anti-adenoviral host factor that is involved in host cell defense mechanisms in productive HAdV-C5 infection. Moreover, these findings suggest that FAM111B might play an important role in the host antiviral immune response that is counteracted by HAdV-C5 E1B-55K and E4orf6 oncoproteins.
Identifiants
pubmed: 34071532
pii: v13061015
doi: 10.3390/v13061015
pmc: PMC8227810
pii:
doi:
Substances chimiques
Adenovirus E1B Proteins
0
Cell Cycle Proteins
0
FAM111B protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Virol. 2015 Nov 04;90(2):930-46
pubmed: 26537675
Cancer Sci. 2020 Jul;111(7):2635-2646
pubmed: 32418298
J Virol. 2013 Jun;87(11):6232-45
pubmed: 23536656
Clin Microbiol Rev. 2014 Jul;27(3):441-62
pubmed: 24982316
Am J Hum Genet. 2013 Dec 5;93(6):1100-7
pubmed: 24268661
Virology. 2007 Jul 20;364(1):36-44
pubmed: 17367836
Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6684-9
pubmed: 17428914
Int J Pediatr Endocrinol. 2017;2017:1
pubmed: 28138333
Genes Dev. 2001 Dec 1;15(23):3104-17
pubmed: 11731475
PLoS Pathog. 2012;8(10):e1002949
pubmed: 23093934
J Virol. 2016 Dec 16;91(1):
pubmed: 27795433
Blood. 2008 Nov 15;112(10):4235-46
pubmed: 18337559
J Virol. 2010 Jul;84(14):7029-38
pubmed: 20484509
Future Microbiol. 2012 Feb;7(2):211-25
pubmed: 22324991
J Virol. 2009 Sep;83(18):9045-56
pubmed: 19587039
Eur J Cell Biol. 1984 Jul;34(2):313-22
pubmed: 6236979
Mol Cell Biol. 2004 Nov;24(21):9619-29
pubmed: 15485928
Virology. 2017 Apr;504:12-24
pubmed: 28135605
J Virol. 2011 Sep;85(17):8841-51
pubmed: 21715488
J Virol. 2008 Mar;82(6):2642-51
pubmed: 18184699
Clin Genet. 2014 Oct;86(4):394-5
pubmed: 24635597
Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):3720-3725
pubmed: 28320935
Onco Targets Ther. 2019 Apr 17;12:2829-2842
pubmed: 31114230
J Virol. 2018 Dec 10;93(1):
pubmed: 30333173
Database (Oxford). 2016 Jul 03;2016:
pubmed: 27374120
Nat Genet. 2012 Feb 26;44(4):426-9, S1
pubmed: 22366784
Methods Mol Med. 2007;130:29-39
pubmed: 17401162
J Virol. 2018 Jan 30;92(4):
pubmed: 29167340
Nucleic Acids Res. 2009 Mar;37(4):1095-106
pubmed: 19129215